1	Control	Control	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	cell	cell	_	_	_	_	_	_	_
4	cycle	cycle	_	_	_	_	_	_	_
5	entry	entry	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	apoptosis	apoptosis	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	B	B	_	_	_	_	_	_	_
10	lymphocytes	lymphocyte	_	_	_	_	_	_	_
11	infected	infect	_	_	_	_	_	_	_
12	by	by	_	_	_	_	_	_	_
13	Epstein-Barr	epstein-barr	_	_	_	_	_	_	_
14	virus	virus	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	Infection	infection	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	human	human	_	_	_	_	_	_	_
4	B	B	_	_	_	_	_	_	_
5	cells	cell	_	_	_	_	_	_	_
6	with	with	_	_	_	_	_	_	_
7	Epstein-Barr	epstein-barr	_	_	_	_	_	_	_
8	virus	virus	_	_	_	_	_	_	_
9	(	(	_	_	_	_	_	_	_
10	EBV	EBV	_	_	_	_	_	_	_
11	)	)	_	_	_	_	_	_	_
12	results	result	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	activation	activation	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	cell	cell	_	_	_	_	_	_	_
18	cycle	cycle	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	cell	cell	_	_	_	_	_	_	_
21	growth	growth	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	To	to	_	_	_	_	_	_	_
2	interpret	interpret	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	mechanisms	mechanism	_	_	_	_	_	_	_
5	by	by	_	_	_	_	_	_	_
6	which	which	_	_	_	_	_	_	_
7	EBV	EBV	_	_	_	_	_	_	_
8	activates	activate	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	cell	cell	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	we	we	_	_	_	_	_	_	_
13	have	have	_	_	_	_	_	_	_
14	assayed	assay	_	_	_	_	_	_	_
15	many	many	_	_	_	_	_	_	_
16	proteins	protein	_	_	_	_	_	_	_
17	involved	involve	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	control	control	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	G0	g0	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	G1	g1	_	_	_	_	_	_	_
25	phases	phase	_	_	_	_	_	_	_
26	of	of	_	_	_	_	_	_	_
27	the	the	_	_	_	_	_	_	_
28	cell	cell	_	_	_	_	_	_	_
29	cycle	cycle	_	_	_	_	_	_	_
30	and	and	_	_	_	_	_	_	_
31	regulation	regulation	_	_	_	_	_	_	_
32	of	of	_	_	_	_	_	_	_
33	apoptosis	apoptosis	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	EBV	EBV	_	_	_	_	_	_	_
3	infection	infection	_	_	_	_	_	_	_
4	most	most	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	changes	change	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	including	include	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	early	early	_	_	_	_	_	_	_
12	induction	induction	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	cyclin	cyclin	_	_	_	_	_	_	_
15	D2	d2	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	are	be	_	_	_	_	_	_	_
18	dependent	dependent	_	_	_	_	_	_	_
19	on	on	_	_	_	_	_	_	_
20	expression	expression	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	EBV	EBV	_	_	_	_	_	_	_
23	genes	gene	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	but	but	_	_	_	_	_	_	_
26	an	an	_	_	_	_	_	_	_
27	alteration	alteration	_	_	_	_	_	_	_
28	in	in	_	_	_	_	_	_	_
29	the	the	_	_	_	_	_	_	_
30	E2F-4	e2f-4	_	_	_	_	_	_	_
31	profile	profile	_	_	_	_	_	_	_
32	was	be	_	_	_	_	_	_	_
33	partly	partly	_	_	_	_	_	_	_
34	independent	independent	_	_	_	_	_	_	_
35	of	of	_	_	_	_	_	_	_
36	viral	viral	_	_	_	_	_	_	_
37	gene	gene	_	_	_	_	_	_	_
38	expression	expression	_	_	_	_	_	_	_
39	,	,	_	_	_	_	_	_	_
40	presumably	presumably	_	_	_	_	_	_	_
41	occurring	occur	_	_	_	_	_	_	_
42	in	in	_	_	_	_	_	_	_
43	response	response	_	_	_	_	_	_	_
44	to	to	_	_	_	_	_	_	_
45	signal	signal	_	_	_	_	_	_	_
46	transduction	transduction	_	_	_	_	_	_	_
47	activated	activate	_	_	_	_	_	_	_
48	when	when	_	_	_	_	_	_	_
49	the	the	_	_	_	_	_	_	_
50	virus	virus	_	_	_	_	_	_	_
51	binds	bind	_	_	_	_	_	_	_
52	to	to	_	_	_	_	_	_	_
53	its	its	_	_	_	_	_	_	_
54	receptor	receptor	_	_	_	_	_	_	_
55	,	,	_	_	_	_	_	_	_
56	CD21	CD21	_	_	_	_	_	_	_
57	.	.	_	_	_	_	_	_	_

1	By	by	_	_	_	_	_	_	_
2	comparing	compare	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	expression	expression	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	genes	gene	_	_	_	_	_	_	_
7	controlling	control	_	_	_	_	_	_	_
8	apoptosis	apoptosis	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	including	include	_	_	_	_	_	_	_
11	those	those	_	_	_	_	_	_	_
12	encoding	encode	_	_	_	_	_	_	_
13	several	several	_	_	_	_	_	_	_
14	members	member	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	BCL-2	bcl-2	_	_	_	_	_	_	_
18	family	family	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	proteins	protein	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	known	known	_	_	_	_	_	_	_
24	relative	relative	_	_	_	_	_	_	_
25	resistance	resistance	_	_	_	_	_	_	_
26	of	of	_	_	_	_	_	_	_
27	EBV-immortalized	ebv-immortalized	_	_	_	_	_	_	_
28	B-cell	b-cell	_	_	_	_	_	_	_
29	lines	line	_	_	_	_	_	_	_
30	to	to	_	_	_	_	_	_	_
31	apoptosis	apoptosis	_	_	_	_	_	_	_
32	induced	induce	_	_	_	_	_	_	_
33	by	by	_	_	_	_	_	_	_
34	low	low	_	_	_	_	_	_	_
35	serum	serum	_	_	_	_	_	_	_
36	was	be	_	_	_	_	_	_	_
37	found	find	_	_	_	_	_	_	_
38	to	to	_	_	_	_	_	_	_
39	correlate	correlate	_	_	_	_	_	_	_
40	with	with	_	_	_	_	_	_	_
41	expression	expression	_	_	_	_	_	_	_
42	of	of	_	_	_	_	_	_	_
43	both	both	_	_	_	_	_	_	_
44	BCL-2	bcl-2	_	_	_	_	_	_	_
45	and	and	_	_	_	_	_	_	_
46	A20	A20	_	_	_	_	_	_	_
47	.	.	_	_	_	_	_	_	_

1	A20	A20	_	_	_	_	_	_	_
2	can	can	_	_	_	_	_	_	_
3	be	be	_	_	_	_	_	_	_
4	regulated	regulate	_	_	_	_	_	_	_
5	by	by	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
8	transcription	transcription	_	_	_	_	_	_	_
9	factor	factor	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	which	which	_	_	_	_	_	_	_
12	is	be	_	_	_	_	_	_	_
13	known	know	_	_	_	_	_	_	_
14	to	to	_	_	_	_	_	_	_
15	be	be	_	_	_	_	_	_	_
16	activated	activate	_	_	_	_	_	_	_
17	by	by	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	EBV	EBV	_	_	_	_	_	_	_
20	LMP-1	lmp-1	_	_	_	_	_	_	_
21	protein	protein	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Quantitative	quantitative	_	_	_	_	_	_	_
2	assays	assay	_	_	_	_	_	_	_
3	demonstrated	demonstrate	_	_	_	_	_	_	_
4	a	a	_	_	_	_	_	_	_
5	direct	direct	_	_	_	_	_	_	_
6	temporal	temporal	_	_	_	_	_	_	_
7	relationship	relationship	_	_	_	_	_	_	_
8	between	between	_	_	_	_	_	_	_
9	LMP-1	lmp-1	_	_	_	_	_	_	_
10	protein	protein	_	_	_	_	_	_	_
11	levels	level	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	active	active	_	_	_	_	_	_	_
14	NF-kappaB	nf-kappab	_	_	_	_	_	_	_
15	during	during	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	time	time	_	_	_	_	_	_	_
18	course	course	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	infection	infection	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

